After a long time some developments on acquisition as Investor Presentation is not released yet.
Sub: Acquisition of Assets
This is to inform you that pursuant to an agreement entered into by Kopran Research Laboratories Limited, the wholly owned subsidiary of Kopran Limited, it has acquired the assets of an API manufacturing Unit of Abhinandan Rasayan Private Limited located at MIDC – Ambernath, subject to certain terms and conditions as mentioned in the said agreement. Pursuant to the said acquisition, once the unit is made fully functional, it will help the Company in increasing its API and intermediate production capacity.
Abhinandan Rasayan Private Limited (ARPL)
Lasa Supergenerics Ltd has acquired the assets (which includes land and building with entire plant and Machinery) of ARPL for a total consideration of Rs.15 crore via memorandum of understanding dated March 18, 2018.
The Said acquisition was under dispute due to alleged collusion between lender and Abhinandan Rasayan Pvt. Ltd. to save Abhinandan Rasayan Pvt. Ltd. account turn bad in Lenders Books.
Due to the alleged foul play by other parties the deal stood cancelled as transaction did not succeed within stipulated period.
Production Capacity of ARPL at Ambernath
Sales and EBIDTA Margin Target from the new plant will be key thing to watch and consideration for the acquisition . It should be less than 15 crore.
Subscribe To Our Free Newsletter |